BKT-300 is a potent and selective inhibitor of Protein regulator of cytokinesis 1 (PRC1), with a Kd value of 28.3 nM. It disrupts microtubule architecture, induces G2/M phase arrest, mitotic catastrophe, and caspase-3-dependent apoptosis, presenting potential as a novel therapy for advanced acute myeloid leukemia (AML).
Molecular Weight:
399.44
CAS Number:
[2551033-16-8]
Formula:
C22H25NO6
Target:
Others
T207784
* VAT and and shipping costs not included. Errors and price changes excepted
